Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast calculations
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing burden of cardiovascular diseases
3.2.1.2 Technological advancements
3.2.1.3 Favorable reimbursement scenario
3.2.1.4 Rising preference for minimally invasive procedures
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent regulatory policies
3.2.2.2 Potential complications and adverse events
3.3 Growth potential analysis
3.4 Porter's analysis
3.4.1 Supplier power
3.4.2 Buyer power
3.4.3 Threat of new entrants
3.4.4 Threat of substitutes
3.4.5 Industry rivalry
3.5 PESTEL analysis
3.6 Pricing analysis, 2023
3.7 Reimbursement scenario
3.8 Regulatory landscape
3.9 Technological landscape
3.10 Future market trends
3.11 GAP analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Heart valve devices
5.2.1 Surgical heart valves
5.2.2 Transcatheter heart valves
5.3 Annuloplasty rings
5.4 Occluders & delivery systems
5.5 Other products
Chapter 6 Market Estimates and Forecast, By Procedure, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Replacement procedures
6.2.1 Surgical aortic valve replacement (SAVR)
6.2.2 Transcatheter aortic valve replacement (TAVR)
6.2.3 Transcatheter mitral valve replacement (TMVR)
6.2.4 Other replacement procedures
6.3 Repair procedures
6.3.1 Left atrial appendage closure (LAAC)
6.3.2 Transcatheter mitral valve repair (TMVr)
6.3.3 Transcatheter tricuspid valve repair (TTVr)
6.3.4 Valvuloplasty
6.3.5 Other repair procedures
Chapter 7 Market Estimates and Forecast, By End-use, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospitals
7.3 Ambulatory surgical centers
7.4 Cardiac catheterization labs
7.5 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 China
8.4.2 Japan
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Argentina
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 AtriCure, Inc.
9.3 Biomerics, LLC
9.4 Boston Scientific Corporation
9.5 Braile Biomedica
9.6 Cryolife Inc.
9.7 Edwards Lifesciences Corporation
9.8 JenaValve Technology, Inc.
9.9 Lepu Medical Technology(Beijing)Co.,Ltd.
9.10 LivaNova PLC
9.11 Medtronic plc
9.12 NuMed Inc.
